Drug recall: Class-action request filed in Montreal

A request for a class-action suit filed in the Montreal courthouse on Monday wants the manufacturers of a recalled heart medication, valsartan, to pay damages to Quebecers who took the drug.
A recall issued by Health Canada on July 9, 2018, announced that several drugs containing valsartan were contaminated with an impurity: a chemical called N-nitrosodimethylamine, otherwise known as NDMA.
NDMA is a potential human carcinogen, which means long-term exposure to it could cause cancer, according t